MOLLAI
"MOLLAI" is a trademark owned by Abcam Limited, filed at the WIPO on July 10, 2026. It is on file and covers classes 9 and 42.
- Status
- Mixed
- Filed
- July 10, 2026
- Registered
- Not yet
- Expires
- July 10, 2036
- Application no.
- Not recorded
- Registration no.
- 1940044
- Office
- WIPO
- World Intellectual Property Organization
- Mark type
- Trademark
- 2 classes
Who owns MOLLAI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Abcam Limited
Representative
Wiggin LLP
Wiggin LLP
What the mark covers
The products and services MOLLAI is filed for, grouped by Nice class.
Downloadable artificial intelligence software for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; downloadable artificial intelligence software for retrieving, indexing and correlating scientific publications, research data, institutions, funding sources and scientific authors in the field of protein and antibody research; downloadable artificial intelligence (AI) software and downloadable machine learning software for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology; downloadable chatbot software for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; downloadable chatbot software for simulating conversations in relation to the field of life sciences and biotechnology.
Software as a service (SaaS) featuring artificial intelligence software for identifying protein targets, correlating scientific publications, analysing research trends and recommending antibodies, proteins and laboratory reagents; providing temporary use of non downloadable artificial intelligence software for natural language processing, data mining, target identification, literature analysis, publication correlation, and product recommendation in the field of life sciences and biotechnology; platform as a service (PaaS) featuring artificial intelligence computer software platforms for research discovery, scientific knowledge retrieval and personalised digital research experiences in the field of life sciences and biotechnology; artificial intelligence as a service (AIaaS) being a chatbot for simulated conversation and performing generative text AI tasks in the field of life sciences and biotechnology; academic research services; biological research, scientific research, clinical research and medical research; software as a service (SaaS) featuring artificial intelligence software for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; software as a service (SaaS) featuring artificial intelligence software for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology; software as a service (SaaS) featuring artificial intelligence software for retrieving, indexing and correlating scientific publications, research data, institutions, funding sources and scientific authors in the field of protein and antibody research; software as a service (SaaS) featuring artificial intelligence software for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; artificial intelligence as a service (AIaaS) being a chatbot for searching, filtering, comparing, recommending and purchasing laboratory reagents, antibodies, proteins, assay kits and research consumables; artificial intelligence as a service (AIaaS) being a chatbot for assisting users with product selection, technical queries, target identification, and literature discovery in the field of life sciences and biotechnology; artificial intelligence as a service (AIaaS) being a chatbot for natural language processing, question answering, recommendation, and predictive analytics in the field of life sciences and biotechnology.
About MOLLAI
Who owns the trademark "MOLLAI"?
The WIPO trademark "MOLLAI" is owned by Abcam Limited.
What is the status of "MOLLAI"?
Its status at the WIPO is: mixed.
Get this data via the API
Everything on this page comes from the Signa API. Pull MOLLAI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_23d60d2f-4fde-499a-801d-25ba1bc5cbb6
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_23d60d2f-4fde-499a-801d-25ba1bc5cbb6",
"object": "trademark",
"mark_text": "MOLLAI",
"status": {
"primary": "mixed",
"stage": "mixed"
},
"office_code": "WO",
"application_number": null,
"filing_date": "2026-07-10",
"nice_classes": [
9,
42
],
"owners": [
{
"name": "Abcam Limited",
"entity_id": "ent_019eb7c0-1db5-7706-82f3-fd684046ff2b"
}
]
}